Lari 12.5mg/250mg Suspension
By Lari
Rx
10ml Suspension in a Bottle

Composition
Pyrimethamine(12.5mg) + Sulfamethoxazole(250mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
October, 2025

liver
When using Lari 12.5mg/250mg Suspension, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while taking Lari 12.5mg/250mg Suspension. It is advisable to consult your doctor for proper guidance on the usage of this medication.

kidney
It is important to use Lari 12.5mg/250mg Suspension cautiously in patients with kidney disease. Adjustments to the dosage may be necessary. Kindly seek advice from your doctor regarding its use.

alcohol
When taking Lari 12.5mg/250mg Suspension, caution is advised when consuming alcohol. It is recommended to consult your doctor for guidance.

driving
It is unknown if Lari 12.5mg/250mg Suspension affects driving ability. Avoid driving if you have symptoms impairing concentration or reaction time.

pregnancy
Lari 12.5mg/250mg Suspension is not recommended during pregnancy due to possible risks to the developing baby. It could be prescribed in rare life-threatening situations if benefits outweigh risks. Please consult your doctor before use.

breastfeeding
Lari 12.5mg/250mg Suspension is considered safe while breastfeeding. Studies indicate minimal transfer to breastmilk without harming the baby. Note a skin rash in the baby is possible.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI MALARIALS |
Action Class | - |
₹60.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025